ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment

Authors

Jeffrey D Steimle, University of Chicago
Chul Kim, University of Chicago
Megan Rowton, University of Chicago
Rangarajan D Nadadur, University of Chicago
Zhezhen Wang, University of Chicago
Matthew Stocker, University of Chicago
Andrew D Hoffmann, University of Chicago
Erika Hanson, University of Chicago
Junghun Kweon, University of Chicago
Tanvi Sinha, University of California, San Francisco
Kyunghee Choi, Washington University School of Medicine in St. Louis
Brian L Black, University of California, San Francisco
John M Cunningham, University of Chicago
Ivan P Moskowitz, University of Chicago
Kohta Ikegami, University of Cincinnati

Journal

Cell Reports

Publication Date

6-27-2023

Volume

42

Issue

6

First Page

112665

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2023.112665

Rights and Permissions

Steimle JD, Kim C, Rowton M, Nadadur RD, Wang Z, Stocker M, Hoffmann AD, Hanson E, Kweon J, Sinha T, Choi K, Black BL, Cunningham JM, Moskowitz IP, Ikegami K. ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. Cell Rep. 2023 Jun 27;42(6):112665. doi: 10.1016/j.celrep.2023.112665. Copyright 2023 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Steimle, Jeffrey D; Kim, Chul; Rowton, Megan; Nadadur, Rangarajan D; Wang, Zhezhen; Stocker, Matthew; Hoffmann, Andrew D; Hanson, Erika; Kweon, Junghun; Sinha, Tanvi; Choi, Kyunghee; Black, Brian L; Cunningham, John M; Moskowitz, Ivan P; and Ikegami, Kohta, "ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment." Cell Reports. 42, 6. 112665 (2023).
https://digitalcommons.wustl.edu/oa_4/2381

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.